STAT3d
Merck’s earnings miss focused attention on Gardasil. The real issue is Keytruda
Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of ...
Merck’s struggles with HPV vaccine send stock to worst selloff in almost 17 years
Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset ...
FiercePharma3d
Merck halts Gardasil shipments to China, withdraws $11B sales target as demand nosedives
The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is halting shipments to the world’s second-most populous country.
Merck shares plunge as company pauses Gardasil vaccine shipments in China, hurting 2025 outlook
Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...
Kennedy to divest interest from HPV vaccine lawsuits
President Donald Trump’s Health and Human Services nominee said he will divest his interest in lawsuits against an HPV ...
NBC Connecticut4d
Merck's 2025 revenue outlook falls short as it pauses Gardasil vaccine shipments to China
a vaccine that prevents cancer from HPV, into China beginning in February through and going through at least mid-2025. Merck reported fourth-quarter revenue and adjusted earnings that topped ...
The Globe and Mail4d
Merck stops Gardasil shipments to China, hitting 2025 outlook
Merck said on Tuesday it would not ship its HPV vaccine Gardasil in China until at least the middle of this year due to weak discretionary spending, a move that dented its full-year forecast and ...
Morningstar4d
Merck's struggles with HPV vaccine send stock to worst selloff in almost 17 years
Merck issued guidance for 2025 that lags consensus ... after the drug company's softer-than-expected guidance amid struggles for its HPV vaccine in China overshadowed a quarterly earnings beat.